---
$id: https://graph.org.ai/products/commodity/51271613
$type: Product
source: UNSPSC
code: "51271613"
title: "Lidocaine"
class: "51271600"
classTitle: "Anaesthetic amides"
family: "51270000"
familyTitle: "Anaesthetic drugs and related adjuncts and analeptics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Lidocaine

**UNSPSC Code**: 51271613
**Class**: [Anaesthetic amides](Anaesthetic amides.mdx)
**Family**: [Anaesthetic drugs and related adjuncts and analeptics](../Anaesthetic drugs and related adjuncts and analeptics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a cation channel blocker and anesthetic agent with the molecular formula C14H22N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 98PI200987, chemically known as 2-diethylamino-n-(2,6-dimethylphenyl)-ethanamide but generally known as lidocaine, which bears US NIH Compound Identifier 3676. European Medicines Agency schedules Lidocaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08507MIG. The term LIDOCAINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). World Health Organization schedules lidocaine in its Anatomical Therapeutic Chemical (ATC) Classification. LIDOCAINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lidocaine under HS 29242910 and SITC 51479. As of Q4 2014, LIDOCAINE remains the US FDA Preferred Term for this commodity. Lidocaine bears US NLM identifiers UMLS ID C0023660 and NCI Concept Code C614. SMILES: O=C(NC1C(CCCC1C)C)CN(CC)CC.

